Akili, Inc.

Social Capital Suvretta Holdings Corp. I, trading on Nasdaq under the ticker DNAA, was sponsored by a partnership between Social Capital and Suvretta Capital Management and completed its business combination with Akili, Inc., a Boston-based digital therapeutics company. The SPAC went public in 2021 and announced its merger with Akili in January 2022, targeting the healthcare and medtech sector. Akili develops prescription digital therapeutics for cognitive conditions, including EndeavorRx, an FDA-authorized software-based treatment for pediatric ADHD. The transaction is now closed, and the combined company subsequently traded on Nasdaq under the ticker AKLI. Sign up at SpacDesk for complete deal data, filing history, and analytics on this and every other SPAC transaction in our database.

SPAC Counterparty (1)